Back
Regulus Therapeutics Quote, Financials, Valuation and Earnings
The Tech Disruption Wall Street Isn't Talking About...Yet
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
26
RGLS
Regulus Therapeutics
Last Price:
1.58
Seasonality Move:
15.35%
7 Day Trial
ALL ACCESS PASS
$
7
Forget Bitcoin - This Is the Real Opportunity of 2024
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.Regulus Therapeutics Price Quote
$1.58
Regulus Therapeutics Key Stats
Sell
26
Regulus Therapeutics (RGLS)
is a Sell
Day range:
$1.58 - $1.67
52-week range:
$1.08 - $3.79
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
1.05%
Volume:
216.7K
Avg. volume:
340.1K
1-year change:
14.49%
Market cap:
$103.4M
Revenue:
$0
EPS:
$-1.25
How Much Does Regulus Therapeutics Make?
Data Unavailable
Is Regulus Therapeutics Growing As A Company?
Data Unavailable
Regulus Therapeutics Stock Price Performance
-
Did Regulus Therapeutics Stock Go Up Last Month?
Regulus Therapeutics share price went down by -1.25% last month -
Did RGLS's Share Price Rise Over The Last Year?
RGLS share price rose by 14.49% over the past 1 year
What Is Regulus Therapeutics 52-Week High & Low?
-
What Is Regulus Therapeutics’s 52-Week High Share Price?
Regulus Therapeutics has traded as high as $3.79 over the past 52 weeks -
What Is Regulus Therapeutics’s 52-Week Low Share Price?
Regulus Therapeutics has traded as low as $1.08 over the past 52 weeks
Regulus Therapeutics Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Regulus Therapeutics?
-
How Much Debt Does Regulus Therapeutics Have?
Total long term debt quarterly is $0 -
How Much Cash Does Regulus Therapeutics Have?
Cash and short term investments quarterly total is $94.5M -
What Is Regulus Therapeutics’s Book Value Per Share?
Book value per share is 1.50
Is Regulus Therapeutics Cash Flow Positive?
-
What Is RGLS Cash Flow From Operations?
Cash flow from operations (TTM) is -$32.8M -
What Is Regulus Therapeutics’s Cash Flow From Financing?
Cash flow from financing (TTM) is $91.8M -
What Is Regulus Therapeutics’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$79.1M
Regulus Therapeutics Return On Invested Capital
Data Unavailable
Regulus Therapeutics Earnings Date & Stock Price
-
What Is Regulus Therapeutics's Stock Price Today?
A single share of RGLS can be purchased today for 1.58 -
What Is Regulus Therapeutics’s Stock Symbol?
Regulus Therapeutics trades on the nasdaq under the ticker symbol: RGLS -
When Is Regulus Therapeutics’s Next Earnings Date?
The next quarterly earnings date for Regulus Therapeutics is scheduled on November 8, 2024 -
When Is RGLS's next ex-dividend date?
Regulus Therapeutics's next ex-dividend date is October 6, 2024 -
How To Buy Regulus Therapeutics Stock?
You can buy Regulus Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Regulus Therapeutics Competitors
-
Who Are Regulus Therapeutics's Competitors?
Below is a list of companies who compete with Regulus Therapeutics or are related in some way:
Regulus Therapeutics Dividend Yield
-
What Is RGLS Dividend Yield?
Regulus Therapeutics’s dividend yield currently is 0% -
What Is Regulus Therapeutics’s Payout Ratio?
Regulus Therapeutics’s payout ratio is 0% -
When Did Regulus Therapeutics Last Pay A Dividend?
The latest dividend pay date is October 6, 2024 -
What Is Regulus Therapeutics’s Dividend Per Share?
Regulus Therapeutics pays a dividend of $0.00 per share
Regulus Therapeutics Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | -6.25% |
| Revenue: | 0% | 0% |
Analyst Recommendations
| Buy Recommendations: | 4 |
|---|---|
| Hold Recommendations: | 1 |
| Sell Recommendations: | 0 |
| Price Target: | 10.33 |
| Upside from Last Price: | 554.01% |